Donepezil can improve daily activities and promote rehabilitation for severe Alzheimer’s patients in long-term care health facilities

BACKGROUND: Cholinesterase inhibitors can delay the progression of Alzheimer’s disease (AD). Several clinical trials of the drug in moderate to severe AD have consistently reported clinically positive effects. A combining effect with psychosocial intervention was reported in mild to moderate AD pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Meguro, Kenichi, Ouchi, Yoshitaka, Akanuma, Kyoko, Meguro, Mitsue, Kasai, Mari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280048/
https://www.ncbi.nlm.nih.gov/pubmed/25516360
http://dx.doi.org/10.1186/s12883-014-0243-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280048/
https://www.ncbi.nlm.nih.gov/pubmed/25516360
http://dx.doi.org/10.1186/s12883-014-0243-7

Ejemplares similares